Jin, X., Cao, Y., Wang, L., Sun, R., Cheng, L., He, X., . . . Zhao, M. (2019). HLA-matched and HLA-haploidentical allogeneic CD19-directed chimeric antigen receptor T-cell infusions are feasible in relapsed or refractory B-cell acute lymphoblastic leukemia before hematopoietic stem cell transplantation. Leukemia.

Jin, Xin, et al. "HLA-matched and HLA-haploidentical Allogeneic CD19-directed Chimeric Antigen Receptor T-cell Infusions Are Feasible in Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia Before Hematopoietic Stem Cell Transplantation." Leukemia 2019.

Jin, Xin, et al. "HLA-matched and HLA-haploidentical Allogeneic CD19-directed Chimeric Antigen Receptor T-cell Infusions Are Feasible in Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia Before Hematopoietic Stem Cell Transplantation." Leukemia 2019.